Sentiment-Signal
Score-Verlauf (90 Tage)
Stammdaten
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Unternehmen & Branche
| Name | Aspire Biopharma Holdings, Inc. |
|---|---|
| Ticker | ASBP |
| CIK | 0001847345 |
| Sektor | Healthcare |
| Industrie | Biotechnology |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | – |
| Marktkapitalisierung | 785.336 USD |
| Beta | 1,00 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 6,202 | -24,480,848 | -16.38 | 1,312,166 | -6,376,329 |
| 2025-09-30 | 10-Q | -1,850,493 | -0.04 | 2,403,129 | -11,467,278 | |
| 2025-06-30 | 10-Q | -1,981,293 | 989,422 | -9,616,785 | ||
| 2025-03-31 | 10-Q | -15,941,328 | 1,965,514 | -7,952,742 | ||
| 2024-12-31 | 10-K | -1,309,872 | -1.90 | 147,989 | -1,540,088 | |
| 2024-12-31 | 10-Q | -765,710 | 147,989 | -1,540,088 | ||
| 2024-09-30 | 10-Q | -216,269 | -0.01 | 6,663,166 | -774,378 | |
| 2024-06-30 | 10-Q | -96,923 | 6,867,584 | -558,109 | ||
| 2024-03-31 | 10-Q | -230,970 | 20,201,599 | -489,747 | ||
| 2023-12-31 | 10-K | 4,464,079 | 19,982,392 | -487,861 | ||
| 2023-09-30 | 10-Q | -69,258 | 19,893,863 | -62,954 | ||
| 2023-06-30 | 10-Q | 1,811,817 | 20,564,129 | 261,788 | ||
| 2023-03-31 | 10-Q | 2,872,433 | 303,107,536 | -10,262,466 | ||
| 2022-12-31 | 10-K | 3,340,238 | 300,182,005 | -9,937,901 | ||
| 2022-09-30 | 10-Q | 1,077,216 | 297,837,233 | -9,623,871 | ||
| 2022-06-30 | 10-Q | 120,693 | 296,717,778 | -9,368,614 | ||
| 2022-03-31 | 10-Q | -87,826 | 296,502,375 | -9,049,381 | ||
| 2021-12-31 | 10-K | -25,475 | 293,221 | -475 | ||
| 2021-09-30 | 10-Q | -15,310 | 280 | |||
| 2021-06-30 | 10-Q | -2,383 | 15,590 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.